Mafenide → HCID 58985681, 화합물

반응식

[Cl:1][C:2]1[N:7]=[C:6](Cl)[C:5](I)=[CH:4][N:3]=1.[NH2:10][CH2:11][C:12]1[CH:17]=[CH:16][C:15]([S:18]([NH2:21])(=[O:20])=[O:19])=[CH:14][CH:13]=1.CC1(C)C(C)(C)OB([C:30]2[S:31][CH:32]=[CH:33][CH:34]=2)O1>>[Cl:1][C:2]1[N:7]=[C:6]([NH:10][CH2:11][C:12]2[CH:13]=[CH:14][C:15]([S:18]([NH2:21])(=[O:19])=[O:20])=[CH:16][CH:17]=2)[C:5]([C:30]2[S:31][CH:32]=[CH:33][CH:34]=2)=[CH:4][N:3]=1

참가 물질

반응물 3

HCID 3998Mafenide

HCID 2634382,4-Dichloro-5-iodopyrimidine

HCID 107036284,4,5,5-Tetramethyl-2-(thiophen-2-yl)-1,3,2-dioxaborolane

생성물 1

HCID 58985681HCID 58985681, 화합물

실험 절차

Preparation according to procedures 2 and 3 with the use of 2,4-dichloro-5-iodopyrimidine, 4-aminomethyl-benzenesulphonamide and 4,4,5,5-tetramethyl-2-(2-thienyl)-1,3,2-dioxaborolane.

후처리

customPreparation

출처 및 근거

ORD 기록: ord-f0ec42b659814b1eb5389f317207bcf6
출처 데이터셋: uspto-grants-2010_11
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US07825128B2

반응 노트

불러오는 중…